Resmed (RSMDF) Cash from Investing Activities Growth (5y) (2014 - 2026)
Powered by 
Analysis
Resmed (RSMDF) Cash from Investing Activities Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 178.34 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn |
| 4 | Stryker | 104.52 Bn | 101.04 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.61 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.94 Bn | 32.49 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -51.50% |
| Mar 31, 2026 | 0.20% |
| Dec 31, 2025 | -11.42% |
| Sep 30, 2025 | -18.92% |
| Jun 30, 2025 | -108.33% |
| Mar 31, 2025 | 20.42% |
| Dec 31, 2024 | 3.40% |
| Sep 30, 2024 | 15.60% |
| Jun 30, 2024 | -1.17% |
| Mar 31, 2024 | 31.84% |
| Dec 31, 2023 | 42.56% |
| Sep 30, 2023 | -0.11% |
| Jun 30, 2023 | -3.84% |
| Mar 31, 2023 | -7.45% |
| Dec 31, 2022 | -105.14% |
| Sep 30, 2022 | -30.69% |
| Jun 30, 2022 | -12.05% |
| Mar 31, 2022 | -22.53% |
| Dec 31, 2021 | -33.67% |
| Sep 30, 2021 | -26.03% |